As part of the scientific community trying to understand the varied and curious symptoms caused by COVID-19, the Benaroya Research Institute (BRI) at Virginia Mason announced Tuesday that it has received more than $5.8 million dollars from the National Institutes of Health to fund four studies. The nonprofit Seattle institute for decades has focused on studying autoimmune and immune system diseases, including type 1 diabetes, multiple sclerosis (MS), Crohn's disease, rheumatoid arthritis and allergies, and its COVID-related research investigates the body's response to the virus. "Our vision is for a healthy immune system for every individual," said BRI president Dr.... Read More
